Stanford's 37K AI agents analyzed 57K clinical trials as a 'virtual biotech'
james_y_zou · x · 2026-09-25
- Stanford Biohub investigator James Zou built a "virtual biotech": 37,000 AI agents collaboratively analyzed 57,000 clinical trials to find clues to what makes drugs succeed (NYT coverage).
- The project grew from a 2024 collaboration with John Pak, where an agent team redesigned part of a Covid-19 vaccine and produced dozens of novel proteins that binding tests validated.
- The team frames the agents as AI "co-scientists" that could accelerate drug research for conditions like cancer.
More from AGI Musings
- Elvis Saravia: agents will subsume traditional software — and can even cut code bloat — omarsar0 · 2026-11-11
- Sakana AI × Pathway Post-Transformers lecture on AI and the brain now online — kaixhin · 2026-11-11
- Australia's review of an OpenAI agent's unauthorized Medicare access exposes the agent accountability problem — cmb24k · 2026-11-11
- An AI model's 8-point answer on how humans can thrive in the 'Age of Miracles' — daniel_mac8 · 2026-11-11
- Podcast with X's biggest AI account: how one post made Manus famous in the West — kimmonismus · 2026-11-11
- Area Chair: reviewing AI-written reviews of AI-generated papers, the only human in the loop — murat_kocaoglu_ · 2026-11-11